The problem. Standard CRISPR fixes a point mutation by cutting the DNA and hoping the cell uses a supplied template to repair it. That repair path is inefficient in many cells, and the double-strand break invites messy insertions and deletions. For a one-letter change, cutting is the wrong-sized tool.

The idea. The authors fused a cytidine deaminase enzyme to a Cas9 that no longer cuts both strands. The dead or nicking Cas9 parks the complex on the target using its guide RNA, and the deaminase chemically converts a C into a U within a small window, which the cell then reads and copies as a T. So a C-to-T (and on the other strand G-to-A) change is written directly, with no break and no donor template. Adding a repair inhibitor and using a nickase pushed the edit to stick.

Why it matters. This is a genuine shift in what “editing” means: chemistry on a base rather than breaking and repairing the backbone. Since so many pathogenic variants are single substitutions, precise base changes without a double-strand break is exactly the capability the clinic wants. It also shows the dCas9 chassis from CRISPRi as a general delivery platform for a payload.

Verdict. A foundational precision-editing method, later joined by adenine base editors and prime editing. Read it as the first move from cutting to writing single bases.